Zainab Shinkafi-Bagudu Assumes the Role of UICC President
After the Applause: Six ESMO Trials that Changed Cancer Treatment
Meet the International Panelists at OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition
Machine Learning Improves AML Relapse Risk Prediction Beyond ELN 2022: HARMONY Study
ESMO 2026 Guideline: Key Updates in Gastric and Esophageal Cancer Management
UICC Announces New Board of Directors for 2026–2028
Ramy Sedhom: Time Is Money, but for Whom?
11 Colorectal Cancer Trials to Watch at ESMO 2026
The ESMO Guidelines: Real World Cases - Prostate Cancer 2025 is a one-hour live virtual webinar held by the European Society for Medical Oncology (ESMO) on December 3, 2025, at 18:30 CET. Its goal is to disseminate and critically review the updated ESMO Clinical Practice Guidelines for prostate cancer by applying them to a detailed, […]
The ESMO Preceptorship on Gastric Cancer 2025: Singapore is an intensive two-day educational event focused on the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) cancers. Scheduled for December 3–4, […]
The ESMO Preceptorship on Breast Cancer 2025: Singapore is a two-day educational event focused on various aspects of breast cancer management, co-chaired by Rebecca Dent and Matteo Lambertini. Scheduled for […]
ESMO Asia Congress 2025 will be held from December 5-7, 2025 at Singapore, Republic of Singapore. The congress serves as a vital platform to advance cancer care through the latest […]
The ESMO Preceptorship on NSCLC and SCLC 2025 in Singapore, taking place from 8 December 2025 to 9 December 2025, brings together oncology professionals to explore best practices in managing […]
The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members, scheduled for Wednesday, December 10, 2025, at 18:30 CET. Chaired by Dr. Anna Campbell, the Journal Club aims to enhance the understanding and application of the latest research in oncology by focusing on and critically evaluating two newly […]
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings […]
The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC), scheduled for December […]
The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai, scheduled for December 13–14, 2025. This conference, hosted by the Global Healthcare Academy (GHA), is a major […]
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, […]
The ESMO webinar "Therapeutic Landscapes: Toxicity of Cellular Therapies 2026" is a specialized virtual educational session scheduled for January 21, 2026, at 18:30 CET. Led by chairs and speakers Claire […]
The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive, single-day educational symposium scheduled for January 24, 2026, in Jeddah, Saudi Arabia. Organized by the […]
The ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management […]
The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology […]
The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive […]
